Pathstone Holdings’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
17,869
-1,296
| -7% | -$95.1K | 0.01% | 1248 |
|
|
2025
Q1 | $2.19M | Buy |
19,165
+5,951
| +45% | +$679K | 0.01% | 929 |
|
|
2024
Q4 | $666K | Sell |
13,214
-220
| -2% | -$11.1K | ﹤0.01% | 1596 |
|
|
2024
Q3 | $622K | Buy |
13,434
+609
| +5% | +$28.2K | ﹤0.01% | 1621 |
|
|
2024
Q2 | $417K | Buy |
12,825
+3,331
| +35% | +$108K | ﹤0.01% | 1787 |
|
|
2024
Q1 | $239K | Sell |
9,494
-7,974
| -46% | -$201K | ﹤0.01% | 2047 |
|
|
2023
Q4 | $567K | Buy |
+17,468
| New | +$567K | ﹤0.01% | 1422 |
|